C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/96 (2006.01) A61K 31/445 (2006.01) A61K 31/4525 (2006.01) A61K 31/453 (2006.01) A61K 31/4545 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61P 25/18 (2006.01) C07D 405/06 (2006.01)
Patent
CA 2627177
The present invention is directed to piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
La présente invention concerne des dérivés de pipéridine inhibant le transporteur de glycine GlyT1 et pouvant être employés dans le traitement de troubles neurologiques et psychiatriques associés à un dysfonctionnement de la neurotransmission glycinergique ou glutamatergique, et de maladies dans lesquels est impliqué le transporteur de glycine GlyT1.
Hallett David
Lindsley Craig W.
Naylor Elizabeth M.
Nolt Brad M.
Theberge Cory R.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Piperidine glycine transporter inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine glycine transporter inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine glycine transporter inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1927375